mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.006 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.006 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.006 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.006 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.006 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.008 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.008 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.009 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.009 |